It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
"This leads to the prediction that new attempts to create either SARS-CoV-1 vaccines, MERS-CoV vaccines (81), or SARS-CoV-2 vaccines have potentially higher risks for inducing ADE in humans facilitated by antibody infection of phagocytic immune cells. This potential ADE risk is independent of the vaccine technology (82) or targeting strategy selected due to predicted phagocytic immune cell infections upon antibody uptake."
These SARS-CoV vaccines all induced antibody and protection against infection with SARS-CoV. However, challenge of mice given any of the vaccines led to occurrence of Th2-type immunopathology suggesting hypersensitivity to SARS-CoV components was induced. Caution in proceeding to application of a SARS-CoV vaccine in humans is indicated.
originally posted by: sirlancelot
That would correlate with the rush to get everyone vaxxed. The clock is ticking. I know de population was always something the NWO wanted but I still have a hard time believing that they would try to kill millions or even billions. Scary for me to think what kind of pressure they will be putting on the un vaxxed in the near future.
a reply to: GenerationGap
originally posted by: EmmanuelGoldstein
In the near future, after The Great Culling has concluded, and when the elites emerge from their bunkers; the un-vaxxed - with millions or rounds of ammo; will begin the Great Hunting Trip.
We will set sail for New Zealand. And burn it down.
We will storm fortresses in Montana. And burn them down.
We will never forget. And probably never watch another Hollywood movie.
Amen
originally posted by: MDDoxs
originally posted by: EmmanuelGoldstein
In the near future, after The Great Culling has concluded, and when the elites emerge from their bunkers; the un-vaxxed - with millions or rounds of ammo; will begin the Great Hunting Trip.
We will set sail for New Zealand. And burn it down.
We will storm fortresses in Montana. And burn them down.
We will never forget. And probably never watch another Hollywood movie.
Amen
Sounds like a good story. You show write it out.
Current SARS-CoV-2 vaccines appear to be providing protection with high antibody titers; the possibility of ADE risks associated with waning titers of antibodies over time remains unknown.
Limitations of the present studies include their performance in mice only and uncertainty of the relevance of rodent models to SARS-CoV vaccines in humans. Additionally, a more intense study for virus replication including quantitative RT-PCR assays might have confirmed the probability that virus replication is required for induction of the immunopathology after vaccination. Evaluations of mechanisms for the immunopathology, including immunoglobulin and cytokine responses to vaccines and tests for antigen-antibody complexes in tissues exhibiting the reaction, could have strengthened the Th2-type immunopathology finding. Finally, a successful study with a Th1-type adjuvant that did not exhibit the Th2 pathology after challenge would have confirmed a Th2 bias to immune responses as well as provide a potential safe vaccination approach for SARS.
originally posted by: MDDoxs
a reply to: GenerationGap
I think they key here for now per the study;
Current SARS-CoV-2 vaccines appear to be providing protection with high antibody titers; the possibility of ADE risks associated with waning titers of antibodies over time remains unknown.
The second study you posted is from 2012. And acknowledges the following;
Limitations of the present studies include their performance in mice only and uncertainty of the relevance of rodent models to SARS-CoV vaccines in humans. Additionally, a more intense study for virus replication including quantitative RT-PCR assays might have confirmed the probability that virus replication is required for induction of the immunopathology after vaccination. Evaluations of mechanisms for the immunopathology, including immunoglobulin and cytokine responses to vaccines and tests for antigen-antibody complexes in tissues exhibiting the reaction, could have strengthened the Th2-type immunopathology finding. Finally, a successful study with a Th1-type adjuvant that did not exhibit the Th2 pathology after challenge would have confirmed a Th2 bias to immune responses as well as provide a potential safe vaccination approach for SARS.
9 additional years of study should help to address some of the limitations and unknowns. I am currently reviewing for some more contemporary papers to help us in our discussion.
Available data do not indicate a risk of vaccine-enhanced disease, and conversely suggest
effectiveness against severe disease within the available follow-up period. However, risk of
vaccine-enhanced disease over time, potentially associated with waning immunity, remains
unknown and needs to be evaluated further in ongoing clinical trials and in observational studies
that could be conducted following authorization and/or licensure
originally posted by: joejack1949
Does anyone here have the expertise to understand or interpret that first study? I am wishing I got a degree in biology rather than mechanical engineering.
originally posted by: infolurker
a reply to: GenerationGap
Well,
We should know soon for sure.
Israel is over 80% Pfizer vaccinated. If the vaccinated are going to start dropping form ADE issues we will see it there first.
three vaccine preparations were simultaneously evaluated, the double-inactivated (formalin and UV) whole virus vaccine (DIV), the rDNA-expressed S protein vaccine (SV), and the previously evaluated chimeric viral-like particle vaccine (VLP) that had led to immunopathology with virus challenge